- Rating
- 3
- Confidence
- 4
- Informativeness
- 2
- Presentation
- 3
- Soundness
- 2
Read review
Paper summary
This study proposes an observational model that integrates (1) the capture area, (2) the platform, (3) the slide to account for batch effects when pooling data across cohorts in virtual ST applications. The proposed observational model can be integrated with any virtual ST regressor. The model is evaluated with five backbones (Probe, Probe+LoRA, Simple-TF, STPath, STORM) in expert (only Visium or Xenium datasets), and pooled (mixing both modalities) training settings. The evaluation is performed on the HEST Benchmark and also additional tasks including external validation on the newly released Atera platform and spatial clustering. The observation model provides moderate improvements for integrating ST data across modalities. The ablation shows that the platform and slide term drive the gain, not the likelihood alone.
Critical strengths
-
The study is clearly written and allows readers to easily follow it.
-
Easy to be adopted. The observation model proposed in this study can be integrated to any virtual ST regression framework which could benefit existing and future virtual prediction strategies.
-
External validation on newly released ST platforms. The authors assess their observation model on the Atera platform which improves by 10 to 28% on all the five backbones.
Critical weaknesses
-
Contextualization of the work and motivation of the study. Only a few virtual ST works have pooled data across platforms (which is the pooling tested on this work) since batch effects and platform differences are well known issues of spatial transcriptomics. From the cited papers, only STORM (arXiv,2026) integrates data across modalities. Phoenix only trains on Xenium data to explicitly avoid batch effects from pretraining. Another framework that recently incorporates data across multiple models is TissueFormer (Qitian Wu et al, 2026) which should be evaluated with the proposed observation model if possible. In addition, the claim that the sensitivity of Xenium is greater than Visium (section 2.1) has also been previously observed and should be acknowledged (e.g., STP-BENCH, Y. Chung et al., 2026).
-
Methodological innovation. While the proposed observation model is well motivated, some of the components have already been utilized in prior works. As pointed out by the authors in Section 6, count likelihoods (negative binomial likelihood) have already been incorporated in prior studies such as STimage, and also more recent works such sCellST. The authors should also move Related Work (Section 6) to the beginning of the manuscript, to make this explicit and clear for the readers what are the contributions of the work.
-
Moderate and inconsistent improvements. In Table 1 under the Xenium expert setting, the observation counts does not provide consistent improvements and often results in lower performance. While the platform here is just Xenium, the sample and the proposed negative binomial likelihood does not seem to improve.
Questions for authors
Q1. Since the observation model can be applied to any virtual ST regressor, the study would benefit from incorporating common virtual ST framework suchs as STNet (Nat BME, 2020), BLEEP (NeurIPS, 2023), TRIPLEX (CVPR, 2024)… The authors assess Probe, Probe+LoRA, Simple-TF and their implementation of STPath and STORM but conventional ST methods should also be included as part of the benchmarking.
Q2. While Pearson Correlation Coefficient (PCC) is one of the most widely used metrics in virtual ST applications, other metrics are also used. Reporting metrics such as MAE or RMSE would make the claims stronger.
Q3. Are the moderate improvements statistically significant?
Q4. ST data from different modalities is aggregated at different resolutions. Visium is left at the native 55-um spots, while Xenium is pooled in 100 um squares. Many virtual ST methods are now being adopted at the single-cell level (e.g., sCellST, DeepSpot2Cell, GHIST…). Does the benefit of the observation model also holds when Xenium data is pooled into smaller bins or left at its native cell-level?
9 comments
Response to Reviewer xaiV (2/6)
Regarding the methodological novelty (Weakness 2)
As noted in Section 6, count likelihoods have already been used for H&E-to-ST prediction, including the NB likelihood in STimage. The NB distribution is also used in the statistical analysis of ST data; for example, Zhao et al. [1], whom we cite in Section 3, report that ST counts can be modeled with count distributions such as the NB without zero inflation. We therefore agree with the reviewer that the NB likelihood itself is not new, and we do not claim its use as a contribution of this work.
Revised manuscript: Section 6 (Related Work) → Section 2; Section 3 (Method) → Section 4.
In addition, we do not claim that the NB likelihood is the main source of the performance gain. In our ablation (Section 5.3; Appendix H, Table 29), the NB likelihood alone improves over MSE on only 32 of the 50 task–backbone cells, compared with 44 for the full observation model, and the gain comes mainly from the platform and slide terms, as the reviewer also noted in the summary.
Revised manuscript: Section 5.3 → Section 6.3; Appendix H, Table 29 → Appendix I, Table 38.
We would also like to clarify that we chose the NB likelihood not only because the target is a count, but also because it can model how count variability differs across genes and platforms. As described in Section 3, its dispersion has a gene factor and a platform factor, so these differences enter the training objective directly. This makes it well suited to training on data pooled across platforms. We have clarified this motivation in the Introduction of the revised manuscript.
Revised manuscript: Section 3 → Section 4; the motivation is stated in the Introduction (Section 1).
Following the reviewer's suggestion, we have moved the Related Work section to right after the Introduction in the revised manuscript, so that prior work is presented before our analysis and method. In that section, we discuss how prior studies have reported platform differences, addressed batch effects in ST, and used count likelihoods for H&E-to-ST prediction, and then explain what our work adds by modeling platform and slide effects together in the training objective for pooled data. Since this shifts the numbering of the later sections, the section numbers in our responses refer to the submitted manuscript, and the corresponding location in the revised manuscript is given in a quoted line below the paragraph.
Revised manuscript: Related Work is now Section 2, and the extended related work is Appendix A.
[1] Zhao, Peiyao, et al. "Modeling zero inflation is not necessary for spatial transcriptomics." Genome biology 23.1 (2022): 118.
Regarding the moderate and inconsistent improvements (Weakness 3)
We agree that the observation model does not provide consistent improvements in the Xenium expert setting. Over the five Xenium tasks, it yields a significantly lower PCC than MSE training for two of the five backbones: Probe+LoRA (0.515 → 0.497; difference −0.019 before rounding, 95% CI [−0.028, −0.009]) and STORM† (0.449 → 0.431; difference −0.018, 95% CI [−0.028, −0.008]). For the other three backbones (Probe, Simple-TF, and STPath†), the difference is not statistically significant, as the 95% confidence interval includes zero. All intervals are computed with the same bootstrap as in our response to Q3.
We would like to clarify that the proposed model is primarily designed as a training recipe for data pooled across multiple platforms, and that improving single-platform training is not its main target. Even so, it can also improve single-platform training: in the Visium expert setting, it achieves a higher PCC than MSE on all five backbones (Table 1), with significant improvements for Probe and STPath†.
Why the observation model is less effective in the Xenium expert setting than in the Visium expert setting deserves further investigation. Since Xenium is widely used for ST at single-cell resolution, we believe that improving the observation model for training on Xenium alone, as in the Phoenix scenario, is a valuable direction for future work.
Response to Reviewer xaiV (3/6)
Regarding additional baselines (Q1)
We agree that including conventional virtual ST frameworks would strengthen our benchmark. In response to this comment, we trained STNet and TRIPLEX on the pooled set, once with MSE and once with the observation model, and evaluated them on the HEST benchmark (Table R5). Because of the limited time of the discussion period, we could not repeat every experiment of the manuscript for these models, and we report the pooled setting only.
We followed the released architectures and hyperparameters of both models wherever applicable, and used the same data split, gene space, and evaluation protocol as in our main experiments. There are a few departures from the released settings: we increased the batch sizes to speed up training and used UNI2-h features for TRIPLEX's neighbor and global views. Each model was trained with five seeds per objective, with all other settings matched between MSE and the observation model.
Table R5. STNet and TRIPLEX trained on the pooled set with MSE or with the observation model (Obs.): PCC over the 50 benchmark genes on the ten HEST benchmark tasks, mean over five seeds. Mean: the ten-task mean, mean ± sd over seeds. Bold: the better objective per model and task (both when tied at three decimals).
| Model | Objective | READ | CCRCC | HCC | LYMPH | PRAD | COAD | IDC | LUNG | PAAD | SKCM | Mean |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STNet | MSE | −0.000 | 0.117 | 0.034 | 0.144 | 0.207 | 0.351 | 0.423 | 0.496 | 0.389 | 0.285 | 0.244 ± 0.019 |
| Obs. | −0.001 | 0.190 | 0.046 | 0.182 | 0.319 | 0.369 | 0.465 | 0.510 | 0.350 | 0.376 | 0.281 ± 0.004 | |
| TRIPLEX | MSE | 0.238 | 0.210 | 0.094 | 0.250 | 0.331 | 0.530 | 0.622 | 0.628 | 0.487 | 0.661 | 0.405 ± 0.004 |
| Obs. | 0.256 | 0.218 | 0.118 | 0.248 | 0.325 | 0.530 | 0.618 | 0.634 | 0.489 | 0.668 | 0.410 ± 0.003 |
For STNet, replacing the released squared-error loss with the observation model raised the ten-task mean PCC from 0.244 to 0.281, in all five seeds and in 8 of the ten tasks. For TRIPLEX, it raised the ten-task mean PCC from 0.405 to 0.410, in all five seeds and in 7 of the ten tasks.
Response to Reviewer xaiV (1/6)
We sincerely thank Reviewer xaiV for the detailed evaluation and constructive comments on our manuscript. We are pleased that the reviewer found the paper clearly written and easy to follow. We also appreciate the recognition that the observation model is easy to adopt in any virtual ST regression framework and can therefore benefit both existing and future methods. We are glad as well that the reviewer valued the external validation on the newly released Atera platform, where the observation model improves all five backbones by 10–28% on the two samples in the manuscript.
We have carefully considered all of the reviewer's comments and address each of them below.
Regarding the contextualization and motivation of the study (Weakness 1)
We agree that batch effects and platform differences are well-known issues in spatial transcriptomics, as we also note in Sections 1 and 2. The Phoenix study mentioned by the reviewer illustrates this well. It trained only on Xenium data and explicitly excluded all Visium data, citing Visium's lower sensitivity, lateral diffusion, and other artifacts, and it also reported reduced performance when trained on Xenium 5K. Given these issues, training on a single platform is one reasonable approach. In our view, however, such an approach leaves the large number of publicly available Visium slides unused and thus limits the size of the training data. By modeling the differences between platforms and slides explicitly rather than excluding data, our method aims to let such data contribute to training together with data from other platforms.
We also thank the reviewer for pointing out that Phoenix is trained only on Xenium data. In the Introduction, we cited it as an example of pooling slides across cohorts and organs at scale. We agree that it does not combine platforms, and we apologize for the confusion. In the revised manuscript, we have replaced Phoenix in that sentence with TissueFormer, which the reviewer mentioned, and STPath, so that all works cited there (STORM, TissueFormer, and STPath) pool slides across cohorts, organs, and platforms.
Despite these known measurement differences, a growing number of studies use data from multiple platforms together, even when they do not directly predict ST from H&E. MINT [1] fine-tunes a pathology foundation model with ST supervision, using separate expression heads for Visium and Xenium. scGPT-spatial [2] continues the pretraining of the single-cell foundation model scGPT on spots and cells from Visium, Visium HD, Xenium, and MERFISH, with modality tokens and a mixture-of-experts decoder. These approaches handle platform differences with learned embeddings or separate heads, whereas our observation model accounts for them in the training objective, outside the backbone.
We agree that the higher sensitivity of Xenium relative to Visium has been reported before. Section 2.1 cites Janesick et al. (2023) for this, and the revised manuscript also cites STP-Bench, which the reviewer mentioned and which reports the same tendency.
Regarding TissueFormer, which the reviewer suggested evaluating with the observation model, please see our response to Q1, where we report its results together with those of the additional baselines.
[1] Lee, Minsoo, et al. "MINT: molecularly informed training with spatial transcriptomics supervision for pathology foundation models." International Conference on Medical Image Computing and Computer-Assisted Intervention. Cham: Springer Nature Switzerland, 2026.
[2] Wang, Chloe, et al. "scGPT-spatial: continual pretraining of single-cell foundation model for spatial transcriptomics." biorxiv (2025): 2025-02.